Clinical Trials Logo

Other Metastatic Solid Tumors clinical trials

View clinical trials related to Other Metastatic Solid Tumors.

Filter by:
  • None
  • Page 1

NCT ID: NCT03565003 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Start date: November 20, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase 1/2a, open-label, multi-center study of JAB-3068 in Patients with advanced solid tumors.This study has two phases: dose escalation phase and dose expansion phase.

NCT ID: NCT03518554 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors

Start date: April 23, 2018
Phase: Phase 1
Study type: Interventional

This is a phase 1, multi-center, dose escalation, open-label study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of antitumor activity of JAB-3068 in adult patients with advanced solid.